
Nephrology Month in Review: April 2025
The nephrology landscape saw meaningful developments in April, from US Food and Drug Administration action on glomerular diseases to studies highlighting ongoing challenges in chronic kidney disease (CKD) and inequities in renal care. In FDA news, the …